Literature DB >> 12958111

Cohort study on effects of parathyroid surgery on multiple outcomes in primary hyperparathyroidism.

Peter Vestergaard1, Leif Mosekilde.   

Abstract

OBJECTIVES: To assess the effects of surgery compared with conservative treatment (no surgery) for primary hyperparathyroidism.
DESIGN: Cohort study.
SETTING: Nationwide Danish cohort. PARTICIPANTS: 3213 patients, mean age 61 (SD 16) years, with a diagnosis of primary hyperparathyroidism between 1980 and 1999. 1934 (60%) underwent surgery and 1279 (40%) were treated conservatively. MAIN OUTCOME MEASURES: Occurrence of fractures, osteoporosis, kidney or urinary tract stones, acute myocardial infarction, angina pectoris, cardiac arrhythmias, arterial hypertension, heart failure, stroke, acute pancreatitis, stomach or duodenal ulcers, muscle pain, malignant diseases, psychiatric disorders, and mortality.
RESULTS: At diagnosis of primary hyperparathyroidism, patients who subsequently underwent surgery had a lower prevalence of previous fracture (odds ratio 0.64, 95% confidence interval 0.51 to 0.80), acute myocardial infarction (0.59, 0.42 to 0.83), stroke (0.57, 0.37 to 0.88), psychiatric disorders (0.54, 0.31 to 0.94), and painful muscle disorders (0.44, 0.26 to 0.76), whereas kidney stones (2.49, 1.93 to 3.23) and acute pancreatitis (2.77, 1.33 to 5.76) were more prevalent. After diagnosis, the risks of fractures (hazards ratio 0.69, 0.56 to 0.84) and gastric ulcers (0.59, 0.41 to 0.84) were lower in patients treated surgically than those treated conservatively. Events involving kidney or urinary tact stones were more prevalent in patients treated surgically than patients treated conservatively (1.87, 1.30 to 2.68). Mortality was lower in patients treated surgically (0.65, 0.57 to 0.73).
CONCLUSIONS: Patients treated surgically for primary hyperparathyroidism have a lower prevalence of fractures and gastric ulcers than patients treated conservatively. The type of treatment had no effect on the occurrence of cardiovascular events.

Entities:  

Mesh:

Year:  2003        PMID: 12958111      PMCID: PMC192894          DOI: 10.1136/bmj.327.7414.530

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  22 in total

Review 1.  Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century.

Authors:  John P Bilezikian; John T Potts; Ghada El-Hajj Fuleihan; Michael Kleerekoper; Robert Neer; Munro Peacock; Jonas Rastad; Shonni J Silverberg; Robert Udelsman; Samuel A Wells
Journal:  J Bone Miner Res       Date:  2002-11       Impact factor: 6.741

2.  Primary hyperparathyroidism: effect of parathyroidectomy on regional bone mineral density in Danish patients: a three-year follow-up study.

Authors:  P Christiansen; T Steiniche; K Brixen; I Hessov; F Melsen; L Heickendorff; L Mosekilde
Journal:  Bone       Date:  1999-11       Impact factor: 4.398

3.  [Registration of diagnoses in a national patient register. Preliminary assessment of the validity of the register].

Authors:  H J Jürgensen; C Frølund; J Gustafsen; H Mosbech; B Guldhammer
Journal:  Ugeskr Laeger       Date:  1984-10-22

4.  Cohort study of risk of fracture before and after surgery for primary hyperparathyroidism.

Authors:  P Vestergaard; C L Mollerup; V G Frøkjaer; P Christiansen; M Blichert-Toft; L Mosekilde
Journal:  BMJ       Date:  2000-09-09

5.  Risk of renal stone events in primary hyperparathyroidism before and after parathyroid surgery: controlled retrospective follow up study.

Authors:  Charlotte L Mollerup; Peter Vestergaard; Vibe Gedsø Frøkjaer; Leif Mosekilde; Peer Christiansen; Mogens Blichert-Toft
Journal:  BMJ       Date:  2002-10-12

6.  Randomized trial of parathyroidectomy in mild asymptomatic primary hyperparathyroidism: patient description and effects on the SF-36 health survey.

Authors:  G B Talpos; H G Bone; M Kleerekoper; E R Phillips; M Alam; M Honasoge; G W Divine; D S Rao
Journal:  Surgery       Date:  2000-12       Impact factor: 3.982

7.  Hypertension and hyperparathyroidism. Inverse relation of serum phosphate level and blood pressure.

Authors:  J Daniels; A D Goodman
Journal:  Am J Med       Date:  1983-07       Impact factor: 4.965

8.  Pancreatitis associated with primary hyperparathyroidism.

Authors:  D Paloyan; D Simonowitz; E Paloyan; T J Snyder
Journal:  Am Surg       Date:  1982-08       Impact factor: 0.688

9.  Effect of chronic hypercalcemia on the heart. An analysis of 18 necropsy patients.

Authors:  W C Roberts; B F Waller
Journal:  Am J Med       Date:  1981-09       Impact factor: 4.965

10.  Primary hyperparathyroidism. Incidence, morbidity, and potential economic impact in a community.

Authors:  H Heath; S F Hodgson; M A Kennedy
Journal:  N Engl J Med       Date:  1980-01-24       Impact factor: 91.245

View more
  22 in total

1.  Prevalence of cardiovascular risk factors in male and female patients with primary hyperparathyroidism.

Authors:  D Han; S Trooskin; X Wang
Journal:  J Endocrinol Invest       Date:  2011-07-12       Impact factor: 4.256

2.  Hypercalcemic States associated with nephrolithiasis.

Authors:  Brandon L Craven; Corey Passman; Dean G Assimos
Journal:  Rev Urol       Date:  2008

Review 3.  Simplified minimally invasive parathyroidectomy: a series of 100 cases and review of the literature.

Authors:  W Wong; F J Foo; M I Lau; A Sarin; P Kiruparan
Journal:  Ann R Coll Surg Engl       Date:  2011-05       Impact factor: 1.891

4.  Myocardial perfusion defects and the left ventricular ejection fraction disclosed by scintigraphy in patients with primary hyperparathyroidism.

Authors:  Christina Gerlach Ogard; Susanne Bonnichsen Søndergaard; Henrik Vestergaard; Henrik Jakobsen; Steen Levin Nielsen
Journal:  World J Surg       Date:  2005-07       Impact factor: 3.352

5.  Incidence and prevalence of primary hyperparathyroidism in a racially mixed population.

Authors:  Michael W Yeh; Philip H G Ituarte; Hui Cynthia Zhou; Stacie Nishimoto; In-Lu Amy Liu; Avital Harari; Philip I Haigh; Annette L Adams
Journal:  J Clin Endocrinol Metab       Date:  2013-02-15       Impact factor: 5.958

6.  Underutilization of parathyroidectomy in elderly patients with primary hyperparathyroidism.

Authors:  Bian Wu; Philip I Haigh; Roy Hwang; Philip H G Ituarte; In-Lu Amy Liu; Theodore J Hahn; Michael W Yeh
Journal:  J Clin Endocrinol Metab       Date:  2010-07-07       Impact factor: 5.958

7.  Skeletal Microstructure and Estimated Bone Strength Improve Following Parathyroidectomy in Primary Hyperparathyroidism.

Authors:  Natalie E Cusano; Mishaela R Rubin; Barbara C Silva; Yu-Kwang Donovan Tay; John M Williams; Sanchita Agarwal; Beatriz Omeragic; X Edward Guo; John P Bilezikian
Journal:  J Clin Endocrinol Metab       Date:  2018-01-01       Impact factor: 5.958

Review 8.  What symptom improvement can be expected after operation for primary hyperparathyroidism?

Authors:  Nadine R Caron; Janice L Pasieka
Journal:  World J Surg       Date:  2009-11       Impact factor: 3.352

9.  Parathyroid Neoplasms: The Army Hospital (Research & Referral) Experience.

Authors:  B Fanthome; R Bharadwaj; K M Suryanarayana
Journal:  Med J Armed Forces India       Date:  2011-07-21

10.  Acute pancreatitis in primary hyperparathyroidism: a population-based study.

Authors:  Teck Kim Khoo; Santhi Swaroop Vege; Haitham S Abu-Lebdeh; Euijung Ryu; Sarah Nadeem; Robert A Wermers
Journal:  J Clin Endocrinol Metab       Date:  2009-03-24       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.